Algo version: 0.98b
Modern Chinese Medicine is listed at the HKSE Exchange
Modern Chinese Medicine [1643.HK]
HKSE Sector: Healthcare Industry:Drug Manufacturers—General

Is Modern Chinese Medicine stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Modern Chinese Medicine pays dividends. Last time was Monday 13th of June 2022 where the investors holding the stock on Wednesday 25th of May 2022 were paid HKD0.0167 per share. Over the last 1 times between 2022 and 2022, Modern Chinese Medicine has paid HKD0.0167 with an average of HKD0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Modern Chinese Medicine 10 years ago, but if you had invested on Friday 15th of January 2021 when the price was HKD1.260, you would have made a loss of HKD-0.950 per share or -75.40%

No, the average daily trading liquidity for Modern Chinese Medicine is HKD129 483 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Modern Chinese Medicine has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 140.70, the company's ability to pay off the debt is good. Modern Chinese Medicine has a good net profit margin of 14.21% and should have high tolerances against inflation.

We have calculated the inflation risk for Modern Chinese Medicine to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.